Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-23-000273

Options or other derivatives

  • Chief Executive Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BLATT LAWRENCE · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X05/form4.xml…